Request for Covid-19 Impact Assessment of this Report
The study is a source of reliable data on:
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends-opportunities-challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan
The Major players reported in the market include:
Novo Nordisk A-S
Eli Lilly and Company
AstraZeneca plc
Biocon Ltd.
Sanofi S.A.
Becton, Dickinson and Company
F. Hoffman-La Roche
Owen Mumford Ltd
Jiangsu Delfu Co., Ltd.
...
Product Segment Analysis:
Reusable Pens
Disposable Pens
Type 3
Application Segment Analysis:
Hospital
Diabetes Clinics- Centers
Application 3
Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified analysis of major market segments
1 Insulin Pen Market Overview
1.1 Product Overview and Scope of Insulin Pen
1.2 Classification of Insulin Pen
1.2.1 Reusable Pens
1.2.2 Disposable Pens
1.2.3 Type 3
1.3 Application of Insulin Pen
1.3.2 Hospital
1.3.3 Diabetes Clinics- Centers
1.3.4 Application 3
1.4 Insulin Pen Market States Status and Prospect (2012-2021) by Regions
1.4.1 United States
1.4.2 China
1.4.3 Europe
1.4.4 Japan
1.5 Global Market Size of Insulin Pen (2012-2021)
1.5.1 Global Insulin Pen Sales and Growth Rate (2012-2021)
1.5.2 Global Insulin Pen Revenue and Growth Rate (2012-2021)
2 Global Economic Impact on Insulin Pen Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
3 Insulin Pen Manufacturing Cost Analysis
3.1 Insulin Pen Key Raw Materials Analysis
3.1.1 Key Raw Materials
3.1.2 Price Trend of Key Raw Materials
3.1.3 Key Suppliers of Raw Materials
3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
3.2.1 Raw Materials
3.2.2 Labor Cost
3.2.3 Manufacturing Process Analysis of Insulin Pen
4 Industrial Chain, Sourcing Strategy and Downstream Buyers
4.1 Insulin Pen Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Insulin Pen Major Manufacturers in 2015
4.4 Downstream Buyers
5 Global Insulin Pen Competition by Manufacturers, Type and Application
5.1 Global Insulin Pen Market Competition by Manufacturers
5.1.1 Global Insulin Pen Sales and Market Share of Key Manufacturers (2012-2017)
5.1.2 Global Insulin Pen Revenue and Share by Manufacturers (2012-2017)
5.2 Global Insulin Pen (Volume and Value) by Type
5.5.1 Global Insulin Pen Sales and Market Share by Type (2012-2017)
5.5.2 Global Insulin Pen Revenue and Market Share by Type (2012-2017)
5.3 Global Insulin Pen (Volume and Value) by Regions
5.3.1 Global Insulin Pen Sales and Market Share by Regions (2012-2017)
5.3.2 Global Insulin Pen Revenue and Market Share by Regions (2012-2017)
5.4 Global Insulin Pen (Volume) by Application
6 United States Insulin Pen (Volume, Value and Sales Price)
6.1 United States Insulin Pen Sales and Value (2012-2017)
6.1.1 United States Insulin Pen Sales and Growth Rate (2012-2017)
6.1.2 United States Insulin Pen Revenue and Growth Rate (2012-2017)
6.1.3 United States Insulin Pen Sales Price Trend (2012-2017)
6.2 United States Insulin Pen Sales and Market Share by Manufacturers
6.3 United States Insulin Pen Sales and Market Share by Type
6.4 United States Insulin Pen Sales and Market Share by Application
7 China Insulin Pen (Volume, Value and Sales Price)
7.1 China Insulin Pen Sales and Value (2012-2017)
7.1.1 China Insulin Pen Sales and Growth Rate (2012-2017)
7.1.2 China Insulin Pen Revenue and Growth Rate (2012-2017)
7.1.3 China Insulin Pen Sales Price Trend (2012-2017)
7.2 China Insulin Pen Sales and Market Share by Manufacturers
7.3 China Insulin Pen Sales and Market Share by Type
7.4 China Insulin Pen Sales and Market Share by Application
8 Europe Insulin Pen (Volume, Value and Sales Price)
8.1 Europe Insulin Pen Sales and Value (2012-2017)
8.1.1 Europe Insulin Pen Sales and Growth Rate (2012-2017)
8.1.2 Europe Insulin Pen Revenue and Growth Rate (2012-2017)
8.1.3 Europe Insulin Pen Sales Price Trend (2012-2017)
8.2 Europe Insulin Pen Sales and Market Share by Manufacturers
8.3 Europe Insulin Pen Sales and Market Share by Type
8.4 Europe Insulin Pen Sales and Market Share by Application
9 Japan Insulin Pen (Volume, Value and Sales Price)
9.1 Japan Insulin Pen Sales and Value (2012-2017)
9.1.1 Japan Insulin Pen Sales and Growth Rate (2012-2017)
9.1.2 Japan Insulin Pen Revenue and Growth Rate (2012-2017)
9.1.3 Japan Insulin Pen Sales Price Trend (2012-2017)
9.2 Japan Insulin Pen Sales and Market Share by Manufacturers
9.3 Japan Insulin Pen Sales and Market Share by Type
9.4 Japan Insulin Pen Sales and Market Share by Application
10 Global Insulin Pen Manufacturers Analysis
10.1 Novo Nordisk A-S
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Product Type, Application and Specification
10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Business Overview
10.2 Eli Lilly and Company
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Product Type, Application and Specification
10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Business Overview
10.3 AstraZeneca plc
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Product Type, Application and Specification
10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Business Overview
10.4 Biocon Ltd.
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Product Type, Application and Specification
10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Business Overview
10.5 Sanofi S.A.
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Product Type, Application and Specification
10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Business Overview
10.6 Becton, Dickinson and Company
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Product Type, Application and Specification
10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Business Overview
10.7 F. Hoffman-La Roche
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Product Type, Application and Specification
10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Business Overview
10.8 Owen Mumford Ltd
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Product Type, Application and Specification
10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Business Overview
10.9 Jiangsu Delfu Co., Ltd.
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Product Type, Application and Specification
10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Business Overview
...
11 Marketing Strategy Analysis, Distributors-Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors-Traders List
12 Market Effect Factors Analysis
12.1 Technology Progress-Risk
12.1.1 Substitutes Threat
12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs-Customer Preference Change
12.3 Economic-Political Environmental Change
13 Global Insulin Pen Market Forecast (2017-2021)
13.1 Global Insulin Pen Sales, Revenue Forecast (2017-2021)
13.2 Global Insulin Pen Sales Forecast by Regions (2017-2021)
13.3 Global Insulin Pen Sales Forecast by Type (2017-2021)
13.4 Global Insulin Pen Sales Forecast by Application (2017-2021)
14 Appendix
Table Classification of Insulin Pen
Figure Global Sales Market Share of Insulin Pen by Type in 2015
Table Applications of Insulin Pen
Figure Global Sales Market Share of Insulin Pen by Application in 2015
Figure United States Insulin Pen Revenue and Growth Rate (2012-2021)
Figure China Insulin Pen Revenue and Growth Rate (2012-2021)
Figure Europe Insulin Pen Revenue and Growth Rate (2012-2021)
Figure Japan Insulin Pen Revenue and Growth Rate (2012-2021)
Figure Global Insulin Pen Sales and Growth Rate (2012-2021)
Figure Global Insulin Pen Revenue and Growth Rate (2012-2021)
Table Global Insulin Pen Sales of Key Manufacturers (2012-2017)
Table Global Insulin Pen Sales Share by Manufacturers (2012-2017)
Figure 2015 Insulin Pen Sales Share by Manufacturers
Figure 2016 Insulin Pen Sales Share by Manufacturers
Table Global Insulin Pen Revenue by Manufacturers (2012-2017)
Table Global Insulin Pen Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Insulin Pen Revenue Share by Manufacturers
Table 2016 Global Insulin Pen Revenue Share by Manufacturers
Table Global Insulin Pen Sales and Market Share by Type (2012-2017)
Table Global Insulin Pen Sales Share by Type (2012-2017)
Figure Sales Market Share of Insulin Pen by Type (2012-2017)
Figure Global Insulin Pen Sales Growth Rate by Type (2012-2017)
Table Global Insulin Pen Revenue and Market Share by Type (2012-2017)
Table Global Insulin Pen Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insulin Pen by Type (2012-2017)
Figure Global Insulin Pen Revenue Growth Rate by Type (2012-2017)
Table Global Insulin Pen Sales and Market Share by Regions (2012-2017)
Table Global Insulin Pen Sales Share by Regions (2012-2017)
Figure Sales Market Share of Insulin Pen by Regions (2012-2017)
Figure Global Insulin Pen Sales Growth Rate by Regions (2012-2017)
Table Global Insulin Pen Revenue and Market Share by Regions (2012-2017)
Table Global Insulin Pen Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Insulin Pen by Regions (2012-2017)
Figure Global Insulin Pen Revenue Growth Rate by Regions (2012-2017)
Table Global Insulin Pen Sales and Market Share by Application (2012-2017)
Table Global Insulin Pen Sales Share by Application (2012-2017)
Figure Sales Market Share of Insulin Pen by Application (2012-2017)
Figure Global Insulin Pen Sales Growth Rate by Application (2012-2017)
Figure United States Insulin Pen Sales and Growth Rate (2012-2017)
Figure United States Insulin Pen Revenue and Growth Rate (2012-2017)
Figure United States Insulin Pen Sales Price Trend (2012-2017)
Table United States Insulin Pen Sales by Manufacturers (2012-2017)
Table United States Insulin Pen Market Share by Manufacturers (2012-2017)
Table United States Insulin Pen Sales by Type (2012-2017)
Table United States Insulin Pen Market Share by Type (2012-2017)
Table United States Insulin Pen Sales by Application (2012-2017)
Table United States Insulin Pen Market Share by Application (2012-2017)
Figure China Insulin Pen Sales and Growth Rate (2012-2017)
Figure China Insulin Pen Revenue and Growth Rate (2012-2017)
Figure China Insulin Pen Sales Price Trend (2012-2017)
Table China Insulin Pen Sales by Manufacturers (2012-2017)
Table China Insulin Pen Market Share by Manufacturers (2012-2017)
Table China Insulin Pen Sales by Type (2012-2017)
Table China Insulin Pen Market Share by Type (2012-2017)
Table China Insulin Pen Sales by Application (2012-2017)
Table China Insulin Pen Market Share by Application (2012-2017)
Figure Europe Insulin Pen Sales and Growth Rate (2012-2017)
Figure Europe Insulin Pen Revenue and Growth Rate (2012-2017)
Figure Europe Insulin Pen Sales Price Trend (2012-2017)
Table Europe Insulin Pen Sales by Manufacturers (2012-2017)
Table Europe Insulin Pen Market Share by Manufacturers (2012-2017)
Table Europe Insulin Pen Sales by Type (2012-2017)
Table Europe Insulin Pen Market Share by Type (2012-2017)
Table Europe Insulin Pen Sales by Application (2012-2017)
Table Europe Insulin Pen Market Share by Application (2012-2017)
Figure Japan Insulin Pen Sales and Growth Rate (2012-2017)
Figure Japan Insulin Pen Revenue and Growth Rate (2012-2017)
Figure Japan Insulin Pen Sales Price Trend (2012-2017)
Table Japan Insulin Pen Sales by Manufacturers (2012-2017)
Table Japan Insulin Pen Market Share by Manufacturers (2012-2017)
Table Japan Insulin Pen Sales by Type (2012-2017)
Table Japan Insulin Pen Market Share by Type (2012-2017)
Table Japan Insulin Pen Sales by Application (2012-2017)
Table Japan Insulin Pen Market Share by Application (2012-2017)
Table Novo Nordisk A-S Basic Information List
Table Novo Nordisk A-S Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk A-S Insulin Pen Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly and Company Insulin Pen Global Market Share (2012-2017)
Table AstraZeneca plc Basic Information List
Table AstraZeneca plc Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca plc Insulin Pen Global Market Share (2012-2017)
Table Biocon Ltd. Basic Information List
Table Biocon Ltd. Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Ltd. Insulin Pen Global Market Share (2012-2017)
Table Sanofi S.A. Basic Information List
Table Sanofi S.A. Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi S.A. Insulin Pen Global Market Share (2012-2017)
Table Becton, Dickinson and Company Basic Information List
Table Becton, Dickinson and Company Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Becton, Dickinson and Company Insulin Pen Global Market Share (2012-2017)
Table F. Hoffman-La Roche Basic Information List
Table F. Hoffman-La Roche Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffman-La Roche Insulin Pen Global Market Share (2012-2017)
Table Owen Mumford Ltd Basic Information List
Table Owen Mumford Ltd Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Owen Mumford Ltd Insulin Pen Global Market Share (2012-2017)
Table Jiangsu Delfu Co., Ltd. Basic Information List
Table Jiangsu Delfu Co., Ltd. Insulin Pen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Jiangsu Delfu Co., Ltd. Insulin Pen Global Market Share (2012-2017)
…
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin Pen
Figure Manufacturing Process Analysis of Insulin Pen
Figure Insulin Pen Industrial Chain Analysis
Table Raw Materials Sources of Insulin Pen Major Manufacturers in 2015
Table Major Buyers of Insulin Pen
Table Distributors-Traders List
Figure Global Insulin Pen Sales and Growth Rate Forecast (2017-2021)
Figure Global Insulin Pen Revenue and Growth Rate Forecast (2017-2021)
Table Global Insulin Pen Sales Forecast by Regions (2017-2021)
Table Global Insulin Pen Sales Forecast by Type (2017-2021)
Table Global Insulin Pen Sales Forecast by Application (2017-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...